Mouse skin painting has long been used to assess the dermal carcinogenic potential of natural and synthetic materials (1) (2) (3) (4) . Compounds derived from petroleum were among the early materials tested by mouse skin painting and were important in demonstrating the carcinogenic potential of compounds such as polycyclic aromatic hydrocarbons (PAHs) of specific structure and elucidating the structure-activity relations now recognized for these compounds.
Early investigators (2, 5) painted the skin of mice for long periods of time until or after the appearance of tumors. Modern investigators using this technique apply materials for periods approximating the lifetime of the mouse, particularly since promulgation of the FDA and EPA Good Laboratory Practice Regulations (6, 7) . It was learned that some materials could cause tumors after a few (or single) applications but only after subsequent longerterm administration of substances that were not necessarily active in the absence of the initial material (8, 9) . The active materials applied first came to be known as initiators, and those applied subsequently for a longer term were termed promoters. In time, a more or less standardized assay was developed to shorten the time required to identify carcinogens and to discriminate between initiators and promoters (10) . This assay, known as the initiation/promotion (I/P) bioassay entails the application of a known or suspected tumor initiator, followed by multiple weekly treatments of a known or suspected tumor promoter.
The I/P bioassay is designed to differentiate substances that produce tumors by genotoxic mechanisms, nongenotoxic mechanisms, or both. Initiation is generally agreed to occur when one or a few cells of a tissue have been exposed to a carcinogen at a level sufficient to cause a precancerous, heritable, somatic, genetic event. A number of characteristics define the initiated cell, including a permanent change in its DNA. Promotion is thought to involve a number of changes in an initiated cell, causing the initiated cell to grow faster than the surrounding normal cells and to develop into a visible neoplasm. Initiating and promoting agents alone do not cause neoplasms to appear, or only rarely so, but in succession elicit both benign and malignant neoplasms.
A number of researchers have investigated the carcinogenicity of various petroleum fractions (11) (12) (13) (14) (15) . They have documented the initiating potential and carcinogenicity of streams containing PAHs of characteristic structure and molecular weight. They have also shown that some fractions, which do not contain significant concentrations of PAHs, are tumorigenic in long-term assays and are promoters but not initiators in the I/P bioassay.
The American Petroleum Institute (API) assembled a task force of petroleum company scientists and engineers to identify the various streams produced in petroleum refineries for which carcinogenicity data would be most useful. These were tested chronically, and a subset, reported in this paper, was also tested using an I/P protocol to accomplish the following objectives: 1) to investigate the carcinogenic potential of a number of petroleum streams of varying volatility and composition; 2) to identify the active streams as promoters or initiators as defined by the I/P test protocol; 3) to investigate the correlation between results obtained in chronic studies and in I/P studies to evaluate the I/P bioassay as a possible less expensive and shorter alternative to the lifetime bioassay.
Methods

Chronic Study
The test articles listed in Table 1 Vacuum residuum was applied as a 50% (w/v) solution in toluene, and the catalytic cracked clarified oil was applied as a 1% (w/v) solution in toluene. All other test articles and toluene were applied neat. DMBA, the usual initiator in promotion investigations, was prepared one time only in acetone at a concentration of 0.1% (w/v). We prepared PMA in acetone every 2 weeks at a concentration of 0.01% (w/v) and stored it protected from light at approximately 0°C.
Male CD-1 mice are routinely used as test animals in I/P studies (12, 15) and were used in this investigation to permit comparison with previous studies. Male CD-I mice were acquired from Charles River Breeding Laboratories (Portage, Michigan). Mice were 4-5 weeks old upon receipt and 7-9 weeks old at study initiation. They were determined to be free of viral antibodies upon arrival and were quarantined for at least 2 weeks before study initiation. Animals were housed singly at the time of randomization for study initiation and remained housed singly throughout the study in suspended stainless-wire cages. Rodent chow 5001 (Ralston Purina Co., St. Louis, Missouri) and tap water were provided ad libitum by means of an automatic watering system. The animal room temperatures were maintained at 21.3YC ± 1.6 (SD), and relative humidity at 54.5% ± 13.3 (SD). Animal rooms were illuminated with fluorescent lights and maintained on a 12-hr light/ dark cycle.
In the initiation phase, we randomly divided 360 mice into 12 groups of 30 each. This number of mice per group has been shown to provide satisfactory sensitivity and selectivity in I/P studies (12, 15) . In addition to the nine test articles, acetone was used as a negative control, and DMBA was the positive control. Because two samples were diluted in toluene, a separate toluene-initiated group was included as a vehicle control. The test articles, acetone, and toluene were applied as five consecutive daily applications of 50 pl. In the positive control group, 50 pl of DMBA (0.1% w/v in acetone) was applied once on the last day of the dosing week. After a 2-week rest period, 50 pl of PMA promoter (0.01% w/v in acetone) was applied to each animal twice weekly for 25 weeks. Physical examinations including observations of dermal masses were performed weekly on all surviving mice until study completion. We sacrificed all mice by intraperitioneal injection of nembutal the week of PMA treatment termination, subjected mice to gross necropsy, and took skin sections for histopathological examination.
In the promotion phase, we randomly divided 630 mice into 21 25 weeks (50 applications). We sacrificed all mice by injection of intraperitoneal nembutal, subjected mice to gross necropsy, and took skin sections for histopathological examination. The procedures for skin preparation, dosing, and examinations were the same as those followed in the chronic study.
The outcome measures were 1) time to appearance of first tumor, 2) number of animals with clinically observed tumors, and 3) number of animals with histologically confirmed tumors. Statistical significance of treatment effect in the initiation study was assessed by comparison with the acetone-initiated group. In the promotion study, each sample had its own DMBAand acetone-initiated groups and comparisons were made between them. We used two different statistical methods in the analysis of these data. For the time to first tumor data, a product-limit survival analysis (17) was used to contrast the survival distributions for the desired pairwise group comparisons. To analyze the number of animals with tumors, a one-tailed Fisher's exact test (18) was performed to determine whether the incidence of histologically confirmed tumors in the sample group was higher than its respective control. The type I error rate used for all statistical comparisons was 5%.
Results
Irritation and inflammation at the dosing site were common in the exposed groups, with the most severe signs noted in mice exposed to light catalytic, cracked tha, does not demonstrate significant tumorigenic potential. This is also true for vacuum residuum, a nonvolatile fraction containing high molecular weight compounds including PAHs. Since this stream was diluted 50% in toluene, statistical comparison was made with the toluene solvent control rather than acetone.
BaP, a strong dermal carcinogen, produced tumors in virtually all exposed animals in this study at a concentration of 0.05%. The only petroleum stream that approached it in activity was catalytic, cracked clarified oil, which achieved 100% incidence at a concentration of 1%. Solvent-refined heavy naphthenic distillate lacked carcinogenic activity in the chronic study.
Except for light paraffinic distillate, the rest of the samples can be characterized as middle distillates with boiling ranges in the region of 150°-370°C. These streams appear to be tumorigenic after chronic dermal application under the conditions of this experiment. The skins of mice chronically exposed to the middle distillate samples evidenced severe irritation with inflammation, some erosion, and scab formation.
The tumors seen in the I/P study were overwhelmingly benign squamous cell papillomas and keratoacanthomas. The only malignant tumors, squamous cell carcinomas, occurred in two mice of the group promoted with light catalytic cracked distillate. The middle distillate samples (hydrodesulfurized kerosene, hydrodesulfurized middle distillate, light catalytic cracked distillate, and the 50/50 mixture of straight run middle distillate/light catalytic cracked distillate) acted as pure promoters in the I/P assay with no significant initiating potential. Lastly, a heterogeneous trio of samples, sweetened naphtha, vacuum residuum, and solvent-refined heavy naphthenic distillate, failed to demonstrate initiating or promoting activity.
In the initiating phase, there was some inverse correlation between tumor incidence and latency with exceptions such as vacuum residuum, which had a low incidence and low latency. This did not appear to be the case in the promoting phase, however, where the latencies were quite similar for all tested groups developing tumors.
As noted previously, the only tumors occurring in chronic and I/P studies at higher than incidental rates were squamous cell carcinomas, squamous cell papillomas, fibrosarcomas, and keratoacanthomas. Table 4 lists the incidence rates of these tumors in both studies. The bulk of the neoplasms in the chronic study were squamous cell carcinomas with a significant representation of the fibrosarcomas and a relatively small incidence of squamous cell papillomas. As Biles et al. (11) used C3H mice in their study of chronic dermal application of middle distillate samples and identified only one fibrosarcoma in 490 mice in the 10 groups tested. It appears that the C3H strain is not consistently susceptible to the development of fibrosarcomas. In any event, the appearance of fibrosarcomas in the chronic study does not affect the good correlation of the I/P study with the chronic investigation as far as tumorigenic activity is concerned. Table 5 summarizes the activity of the various petroleum streams tested in this investigation in both chronic and I/P studies. The results of the chronic bioassay in this investigation are consistent with previous studies (11, 13, 14) , which have shown the following: 1) the most volatile streams are inactive, 2) the least volatile residues (vacuum residuum) are also inactive, 3) untreated distillates (light paraffinic distillate in this study) are active but may be made inactive by suitable treatment to remove PAHs (solvent-refined heavy naphthenic distillate in this study), 4) middle distillates show carcinogenic activity in chronic dermal studies.
The I/P investigations carried out in this study demonstrate convincingly that the middle distillates with carcinogenic activity in the chronic study act as promoters and not as initiators. This too supports results of previous investigations (12, 15 The I/P portion of the investigation demonstrated perfect correlation with the chronic phase in that all streams negative in the chronic bioassay were inactive as initiators and promoters, and all streams positive in the chronic bioassay were active in either the initiation phase or promotion phase or both. This indicates, at least for petroleum streams, that the I/P bioassay may be a cost-effective substitute for the chronic test. Results would be available in 6 months rather than 2 years, providing earlier information at a lower cost. It would also furnish additional information with regard to the nature of the carcinogenic activity, which might be useful in assessing hazard.
The significance of the distinction between initiation and promotion in regard to risk assessment of petroleum streams remains to be clarified, and an API consortium is currently sponsoring research in the field. Over a number of years, hypotheses have been put forth regarding the development of at least some cancers as a two-stage process (24) (25) (26) (27) . These authors and their co-workers have demonstrated that the time course of tumor incidence can be successfully modeled using this approach for naturally occurring tumors in humans (27) or for chemically induced cancers in experimental animals (24, 28 (25) . Because cellular proliferation is a function of the dermal application schedule, which is different in the experimental situation than in human experience, direct extrapolation will probably lead to erroneous conclusions. A better question is why should you have to choose? Why shouldn't every bright, hard-working kid get a chance to fulfill his or her dreams?
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